Prakash Gaba of prakashgaba.com told CNBC-TV18, "Glenmark Pharma certainly looks good to me from a perspective of two years. I don’t think there is much downside here. It has seen a good down move and looks like this is a play maybe at Rs 550 on the lower levels perhaps could be a strong support zone for Glenmark."
"It is bottoming out here; I think Glenmark Pharma for two years space is good," he added.
At 14:26 hrs Glenmark Pharma was quoting at Rs 543.45, up Rs 7.55, or 1.41 percent.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!